Impact of Cataract Surgery on the Incidence and Progression of Dry Eye Disease

December 30, 2024 updated by: Sara Nabil Habeb, Assiut University
Relation between dry eye and cataract

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Study the impact of cataract surgery on the incidence and progression of dry eye disease

Study Type

Observational

Enrollment (Estimated)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Both males and females above 40- year old going cataract surgery

Description

Inclusion Criteria:

  • patients aged above 40-years old undergoing cataract surgery
  • patients without dry eye disease
  • patients with mild to moderate degree of dry eye disease Both gender, male and female

Exclusion Criteria:

  • patients aged less 40-year old undergoing cataract surgery
  • patients with severe degrees of dry eye disease
  • patients with autoimmune disease
  • patients with chronic blepharitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dry eye after cataract surgery
Time Frame: 1 week, 1 month and 3 months
The incidence of new or working dry eye symptoms following cataract surgery
1 week, 1 month and 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
risk factors to dry eye
Time Frame: 1 month
Identification of risk factors associated with postoperative dry eye
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

December 30, 2024

First Submitted That Met QC Criteria

December 30, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 30, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe